The Werner syndrome gene product (WRN): A repressor of hypoxia-inducible factor-1 activity

Experimental Cell Research

Volumn 318, Issue 14, 2012, Pages 1620-1632

  Labbé, Adam ^a   Lafleur, Véronique N ^a   Patten, David A ^a   Robitaille, Geneviève A ^a   Garand, Chantal ^a   Lamalice, Laurent ^a   Lebel, Michel ^a   Richard, Darren E ^a  

^a University Laval   (Canada)

Author keywords

Ascorbate; HIF 1; Hypoxia; Mitochondria; Oxidative stress; Werner syndrome

Indexed keywords

6 PHOSPHOFRUCTOKINASE; ASCORBIC ACID; GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 3; HYPOXIA INDUCIBLE FACTOR 1ALPHA; REACTIVE OXYGEN METABOLITE; STIGMATELLIN; WERNER SYNDROME PROTEIN;

ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; HYDROXYLATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; WERNER SYNDROME;

EID: 84862885341     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2012.04.010     Document Type: Article

References (63)

1. Epstein C.J., Martin G.M., Schultz A.L., Motulsky A.G. Werner's syndrome a review of its symptomatology, natural history, pathologic features, genetics and relationship to the natural ageing process. Medicine (Baltimore) 1966, 45:177-221.
2. Huang S., Lee L., Hanson N.B., Lenaerts C., Hoehn H., Poot M., Rubin C.D., Chen D.F., Yang C.C., Juch H., Dorn T., Spiegel R., Oral E.A., Abid M., Battisti C., Lucci-Cordisco E., Neri G., Steed E.H., Kidd A., Isley W., Showalter D., Vittone J.L., Konstantinow A., Ring J., Meyer P., Wenger S.L., von Herbay A., Wollina U., Schuelke M., Huizenga C.R., Leistritz D.F., Martin G.M., Mian I.S., Oshima J. The spectrum of WRN mutations in Werner syndrome patients. Hum. Mutat. 2006, 27:558-567.
3. Faragher R.G., Kill I.R., Hunter J.A., Pope F.M., Tannock C., Shall S. The gene responsible for Werner syndrome may be a cell division counting gene. Proc. Natl. Acad. Sci. USA 1993, 90:12030-12034.
4. Melcher R., von Golitschek R., Steinlein C., Schindler D., Neitzel H., Kainer K., Schmid M., Hoehn H. Spectral karyotyping of Werner syndrome fibroblast cultures. Cytogenet. Cell Genet. 2000, 91:180-185.
5. Huang S., Beresten S., Li B., Oshima J., Ellis N.A., Campisi J. Characterization of the human and mouse WRN 3'->5' exonuclease. Nucl. Acids Res. 2000, 28:2396-2405.
6. Kamath-Loeb A.S., Shen J.C., Loeb L.A., Fry M. Werner syndrome protein. II. Characterization of the integral 3'->5' DNA exonuclease. J. Biol. Chem. 1998, 273:34145-34150.
7. Shen J.C., Gray M.D., Oshima J., Kamath-Loeb A.S., Fry M., Loeb L.A. Werner syndrome protein. I. DNA helicase and DNA exonuclease reside on the same polypeptide. J. Biol. Chem. 1998, 273:34139-34144.
8. Cheng W.H., Muftuoglu M., Bohr V.A. Werner syndrome protein: functions in the response to DNA damage and replication stress in S-phase. Exp. Gerontol. 2007, 42:871-878.
9. Szekely A.M., Bleichert F., Numann A., Van Komen S., Manasanch E., Ben Nasr A., Canaan A., Weissman S.M. Werner protein protects nonproliferating cells from oxidative DNA damage. Mol. Cell Biol. 2005, 25:10492-10506.
10. Massip L., Garand C., Turaga R.V., Deschenes F., Thorin E., Lebel M. Increased insulin, triglycerides, reactive oxygen species, and cardiac fibrosis in mice with a mutation in the helicase domain of the Werner syndrome gene homolog. Exp. Gerontol. 2006, 41:157-168.
11. Pagano G., Zatterale A., Degan P., d'Ischia M., Kelly F.J., Pallardo F.V., Calzone R., Castello G., Dunster C., Giudice A., Kilinc Y., Lloret A., Manini P., Masella R., Vuttariello E., Warnau M. In vivo prooxidant state in Werner syndrome (WS): results from three WS patients and two WS heterozygotes. Free Radic. Res. 2005, 39:529-533.
12. Massip L., Garand C., Paquet E.R., Cogger V.C., O'Reilly J.N., Tworek L., Hatherell A., Taylor C.G., Thorin E., Zahradka P., Le Couteur D.G., Lebel M. Vitamin C restores healthy ageing in a mouse model for Werner syndrome. FASEB J. 2010, 24:158-172.
13. Evans J.L., Goldfine I.D., Maddux B.A., Grodsky G.M. Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocr. Rev. 2002, 23:599-622.
14. Furukawa S., Fujita T., Shimabukuro M., Iwaki M., Yamada Y., Nakajima Y., Nakayama O., Makishima M., Matsuda M., Shimomura I. Increased oxidative stress in obesity and its impact on metabolic syndrome. J. Clin. Invest. 2004, 114:1752-1761.
15. Martin J., Kelly D.J., Mifsud S.A., Zhang Y., Cox A.J., See F., Krum H., Wilkinson-Berka J., Gilbert R.E. Tranilast attenuates cardiac matrix deposition in experimental diabetes: role of transforming growth factor-beta. Cardiovasc. Res. 2005, 65:694-701.
16. Andreyev A.Y., Kushnareva Y.E., Starkov A.A. Mitochondrial metabolism of reactive oxygen species. Biochemistry (Mosc) 2005, 70:200-214.
17. Semenza G.L. Targeting HIF-1 for cancer therapy. Nat. Rev. Cancer 2003, 3:721-732.
18. Majmundar A.J., Wong W.J., Simon M.C. Hypoxia-inducible factors and the response to hypoxic stress. Mol. Cell 2010, 40:294-309.
19. Kaelin W.G., Ratcliffe P.J. Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. Mol. Cell 2008, 30:393-402.
20. Semenza G.L. Regulation of oxygen homeostasis by hypoxia-inducible factor 1. Physiology (Bethesda) 2009, 24:97-106.
21. Bianchi G., Di Giulio C., Rapino C., Rapino M., Antonucci A., Cataldi A. p53 and p66 proteins compete for hypoxia-inducible factor 1 alpha stabilization in young and old rat hearts exposed to intermittent hypoxia. Gerontology 2006, 52:17-23.
22. Hellwig-Burgel T., Stiehl D.P., Wagner A.E., Metzen E., Jelkmann W. Review: hypoxia-inducible factor-1 (HIF-1): a novel transcription factor in immune reactions. J. Interferon Cytokine Res. 2005, 25:297-310.
23. Kang M.J., Kim H.J., Kim H.K., Lee J.Y., Kim D.H., Jung K.J., Kim K.W., Baik H.S., Yoo M.A., Yu B.P., Chung H.Y. The effect of age and calorie restriction on HIF-1-responsive genes in aged liver. Biogerontology 2005, 6:27-37.
24. Lee S.J., Hwang A.B., Kenyon C. Inhibition of respiration extends C. elegans life span via reactive oxygen species that increase HIF-1 activity. Curr. Biol. 2010, 20:2131-2136.
25. Leiser S.F., Begun A., Kaeberlein M. HIF-1 modulates longevity and healthspan in a temperature-dependent manner. Ageing Cell 2011, 10:318-326.
26. Rapino C., Bianchi G., Di Giulio C., Centurione L., Cacchio M., Antonucci A., Cataldi A. HIF-1alpha cytoplasmic accumulation is associated with cell death in old rat cerebral cortex exposed to intermittent hypoxia. Ageing Cell 2005, 4:177-185.
27. Zinkernagel A.S., Johnson R.S., Nizet V. Hypoxia inducible factor (HIF) function in innate immunity and infection. J. Mol. Med. 2007, 85:1339-1346.
28. Skulachev V.P., Anisimov V.N., Antonenko Y.N., Bakeeva L.E., Chernyak B.V., Erichev V.P., Filenko O.F., Kalinina N.I., Kapelko V.I., Kolosova N.G., Kopnin B.P., Korshunova G.A., Lichinitser M.R., Obukhova L.A., Pasyukova E.G., Pisarenko O.I., Roginsky V.A., Ruuge E.K., Senin I.I., Severina I.I., Skulachev M.V., Spivak I.M., Tashlitsky V.N., Tkachuk V.A., Vyssokikh M.Y., Yaguzhinsky L.S., Zorov D.B. An attempt to prevent senescence: a mitochondrial approach. Biochim. Biophys. Acta 1787, 2009:437-461.
29. Richard D.E., Berra E., Gothie E., Roux D., Pouyssegur J. p42/p44 mitogen-activated protein kinases phosphorylate hypoxia-inducible factor 1alpha (HIF-1alpha) and enhance the transcriptional activity of HIF-1. J. Biol. Chem. 1999, 274:32631-32638.
30. Lauzier M.C., Robitaille G.A., Chan D.A., Giaccia A.J., Richard D.E. (2R)-[(4-Biphenylylsulfonyl)amino]-N-hydroxy-3-phenylpropionamide (BiPS), a matrix metalloprotease inhibitor, is a novel and potent activator of hypoxia-inducible factors. Mol. Pharmacol. 2008, 74:282-288.
31. Robinson K.M., Janes M.S., Beckman J.S. The selective detection of mitochondrial superoxide by live cell imageing. Nat. Protoc. 2008, 3:941-947.
32. Salnikow K., Donald S.P., Bruick R.K., Zhitkovich A., Phang J.M., Kasprzak K.S. Depletion of intracellular ascorbate by the carcinogenic metals nickel and cobalt results in the induction of hypoxic stress. J. Biol. Chem. 2004, 279:40337-40344.
33. Page E.L., Chan D.A., Giaccia A.J., Levine M., Richard D.E. Hypoxia-inducible factor-1alpha stabilization in nonhypoxic conditions: role of oxidation and intracellular ascorbate depletion. Mol. Biol. Cell 2008, 19:86-94.
34. Queval G., Noctor G. A plate reader method for the measurement of NAD, NADP, glutathione, and ascorbate in tissue extracts: application to redox profiling during Arabidopsis rosette development. Anal. Biochem. 2007, 363:58-69.
35. Laughner E., Taghavi P., Chiles K., Mahon P.C., Semenza G.L. HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression. Mol. Cell Biol. 2001, 21:3995-4004.
36. Michaud M.D., Robitaille G.A., Gratton J.P., Richard D.E. Sphingosine-1-phosphate: a novel nonhypoxic activator of hypoxia-inducible factor-1 in vascular cells. Arterioscler. Thromb. Vasc. Biol. 2009, 29:902-908.
37. Patten D.A., Lafleur V.N., Robitaille G.A., Chan D.A., Giaccia A.J., Richard D.E. Hypoxia-inducible factor-1 activation in nonhypoxic conditions: the essential role of mitochondrial-derived reactive oxygen species. Mol. Biol. Cell 2010, 21:3247-3257.
38. 2 sensing. Science 2001, 292:464-468.
39. Bell E.L., Klimova T.A., Eisenbart J., Moraes C.T., Murphy M.P., Budinger G.R., Chandel N.S. The Qo site of the mitochondrial complex III is required for the transduction of hypoxic signaling via reactive oxygen species production. J. Cell Biol. 2007, 177:1029-1036.
40. Gorlach A., Berchner-Pfannschmidt U., Wotzlaw C., Cool R.H., Fandrey J., Acker H., Jungermann K., Kietzmann T. Reactive oxygen species modulate HIF-1 mediated PAI-1 expression: involvement of the GTPase Rac1. Thromb. Haemost 2003, 89:926-935.
41. Guzy R.D., Hoyos B., Robin E., Chen H., Liu L., Mansfield K.D., Simon M.C., Hammerling U., Schumacker P.T. Mitochondrial complex III is required for hypoxia-induced ROS production and cellular oxygen sensing. Cell Metab. 2005, 1:401-408.
42. Yoshida K., Kirito K., Yongzhen H., Ozawa K., Kaushansky K., Komatsu N. Thrombopoietin (TPO) regulates HIF-1alpha levels through generation of mitochondrial reactive oxygen species. Int. J. Hematol. 2008, 88:43-51.
43. Klimova T., Chandel N.S. Mitochondrial complex III regulates hypoxic activation of HIF. Cell Death Differ. 2008, 15:660-666.
44. Sanjuan-Pla A., Cervera A.M., Apostolova N., Garcia-Bou R., Victor V.M., Murphy M.P., McCreath K.J. A targeted antioxidant reveals the importance of mitochondrial reactive oxygen species in the hypoxic signaling of HIF-1alpha. FEBS Lett. 2005, 579:2669-2674.
45. Chua Y.L., Dufour E., Dassa E.P., Rustin P., Jacobs H.T., Taylor C.T., Hagen T. Stabilization of hypoxia-inducible factor-1alpha protein in hypoxia occurs independently of mitochondrial reactive oxygen species production. J. Biol. Chem. 2010, 285:31277-31284.
46. Kashino G., Kodama S., Nakayama Y., Suzuki K., Fukase K., Goto M., Watanabe M. Relief of oxidative stress by ascorbic acid delays cellular senescence of normal human and Werner syndrome fibroblast cells. Free Radic. Biol. Med. 2003, 35:438-443.
47. Kivirikko K.I., Myllyharju J. Prolyl 4-hydroxylases and their protein disulfide isomerase subunit. Matrix Biol. 1998, 16:357-368.
48. Knowles H.J., Raval R.R., Harris A.L., Ratcliffe P.J. Effect of ascorbate on the activity of hypoxia-inducible factor in cancer cells. Cancer Res. 2003, 63:1764-1768.
49. Kaczmarek M., Timofeeva O.A., Karaczyn A., Malyguine A., Kasprzak K.S., Salnikow K. The role of ascorbate in the modulation of HIF-1alpha protein and HIF-dependent transcription by chromium(VI) and nickel(II). Free Radic. Biol. Med. 2007, 42:1246-1257.
50. Korcok J., Dixon S.J., Lo T.C., Wilson J.X. Differential effects of glucose on dehydroascorbic acid transport and intracellular ascorbate accumulation in astrocytes and skeletal myocytes. Brain Res. 2003, 993:201-207.
51. Rivas C.I., Zuniga F.A., Salas-Burgos A., Mardones L., Ormazabal V., Vera J.C. Vitamin C transporters. J. Physiol. Biochem. 2008, 64:357-375.
52. Rumsey S.C., Kwon O., Xu G.W., Burant C.F., Simpson I., Levine M. Glucose transporter isoforms GLUT1 and GLUT3 transport dehydroascorbic acid. J. Biol. Chem. 1997, 272:18982-18989.
53. Lavoie J., Carter R., Drouin R., Lebel M. Increased frequency of multiradial chromosome structures in mouse embryonic fibroblasts lacking functional Werner syndrome protein and poly(ADP-ribose) polymerase-1. Cancer Genet. Cytogenet. 2005, 156:134-143.
54. Mukherjee A.B., Costello C. Aneuploidy analysis in fibroblasts of human premature ageing syndromes by FISH during in vitro cellular ageing. Mech. Ageing. Dev. 1998, 103:209-222.
55. Turaga R.V., Massip L., Chavez A., Johnson F.B., Lebel M. Werner syndrome protein prevents DNA breaks upon chromatin structure alteration. Ageing Cell 2007, 6:471-481.
56. Qiao H., Li L., Qu Z.C., May J.M. Cobalt-induced oxidant stress in cultured endothelial cells: prevention by ascorbate in relation to HIF-1alpha. Biofactors 2009, 35:306-313.
57. Schofield C.J., Ratcliffe P.J. Signalling hypoxia by HIF hydroxylases. Biochem. Biophys. Res. Commun. 2005, 338:617-626.
58. Turaga R.V., Paquet E.R., Sild M., Vignard J., Garand C., Johnson F.B., Masson J.Y., Lebel M. The Werner syndrome protein affects the expression of genes involved in adipogenesis and inflammation in addition to cell cycle and DNA damage responses. Cell Cycle 2009, 8:2080-2092.
59. Inoguchi T., Li P., Umeda F., Yu H.Y., Kakimoto M., Imamura M., Aoki T., Etoh T., Hashimoto T., Naruse M., Sano H., Utsumi H., Nawata H. High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells. Diabetes 2000, 49:1939-1945.
60. Pallardo F.V., Lloret A., Lebel M., d'Ischia M., Cogger V.C., Le Couteur D.G., Gadaleta M.N., Castello G., Pagano G. Mitochondrial dysfunction in some oxidative stress-related genetic diseases: ataxia-Telangiectasia, Down Syndrome, Fanconi Anaemia and Werner Syndrome. Biogerontology 2010, 11:401-419.
61. Labbe A., Garand C., Cogger V.C., Paquet E.R., Desbiens M., Le Couteur D.G., Lebel M. Resveratrol improves insulin resistance hyperglycemia and hepatosteatosis but not hypertriglyceridemia, inflammation, and life span in a mouse model for Werner syndrome. J Gerontol. A Biol. Sci. Med. Sci. 2011, 66:264-278.
62. Arciuch V.G., Alippe Y., Carreras M.C., Poderoso J.J. Mitochondrial kinases in cell signaling: facts and perspectives. Adv. Drug Deliv. Rev. 2009, 61:1234-1249.
63. Massip L., Garand C., Labbe A., Perreault E., Turaga R.V., Bohr V.A., Lebel M. Depletion of WRN protein causes RACK1 to activate several protein kinase C isoforms. Oncogene 2010, 29:1486-1497.